| J1952 | Leuprolide injectable, camcevi, 1 mg | 1,340 | $60 | $86K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 710 | $90 | $61.4K |
| J0897 | Injection, denosumab, 1 mg | 2,220 | $20 | $40K |
| 52000 | In this procedure, the provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystourethroscope, a thin flexible or rigid tube with a… | 120 | $180 | $20.3K |
| 99490 | The clinical staff provides services directed by the provider to support and coordinate a patient’s care across multiple disciplines. The patient has two or more chronic conditions that place the… | 300 | $50 | $14.4K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 110 | $130 | $13.9K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 60 | $130 | $7.7K |
| 99426 | Clinical staff members, directed by a physician or other qualified healthcare professional, perform management and care plan services for a patient with a complex chronic condition, expected to last… | 150 | $50 | $6.9K |
| 51720 | This is a common treatment for bladder cancer. It involves instilling an anticarcinogenic agent into the bladder through a catheter. The provider leaves the agent in the bladder for a period of time… | 80 | $70 | $5.6K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 70 | $70 | $4.5K |